Moderna COVID-19 vaccine

RNA COVID-19 vaccine

Moderna COVID-19 vaccine    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Moderna COVID-19 vaccine: RNA COVID-19 vaccine
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in people aged six months, twelve years, or eighteen years and older. It provides protection against COVID-19 which is caused by infection by the SARS-CoV-2 virus. It is designed to be administered as two or three 0.5 mL doses given by intramuscular injection at an interval of at least 28 days apart.


You Might Like

Moderna sues Pfizer/BioNTech over COVID vaccine

moderna sues pfizer/biontech over covid vaccine
Moderna is suing Pfizer and its German partner BioNTech for alleged patent infringement in the development of the first COVID-19 vaccine approved in the US.
Sky News - Published

Indian Covid vaccines better than Pfizer, Moderna: Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that "Made in India" Covid vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and..
IndiaTimes - Published

Pfizer and Moderna jabs give best overall boost, UK study finds

pfizer and moderna jabs give best overall boost, uk study finds
The Pfizer and Moderna vaccines being used in the UK as boosters prompt the best overall response, according to a UK trial.
Sky News - Published

Omicron variant 'highly infectious' and COVID booster jabs may need 'double' dose, says Moderna CEO

omicron variant 'highly infectious' and covid booster jabs may need 'double' dose, says moderna ceo
The head of drugmaker Moderna said he believes the Omicron variant is "highly infectious" and it is "highly possible" the effectiveness of vaccines is decreasing - adding that boosters may need a..
Sky News - Published

New variant may force drug companies to tweak Covid vaccination plans

The emergence of the Omicron strain could lead drug companies scrambling to the drawing board to tweak their Covid-19 vaccine plans. US firm Novavax and Russia’s Gamaleya Institute said on Monday..
IndiaTimes - Published

With domestic manufacturing picking up pace, India unlikely to buy Pfizer, Moderna vaccines for now: Sources

IndiaTimes - Published

UK regulator approves Moderna COVID-19 vaccine for 12 to 17-year-olds

The UK health regulator has approved the Moderna coronavirus vaccine for 12 to 17-year-olds.
Sky News - Published

Moderna and Pfizer jabs linked to mild heart inflammation but 'benefits still outweigh risks'

moderna and pfizer jabs linked to mild heart inflammation but 'benefits still outweigh risks'
The Pfizer/BioNTech and Moderna jabs have been linked to cases of mild heart inflammation - but the benefits still outweigh the risks, according to European and UK health agencies.
Sky News - Published

India expects 3-4 million Pfizer, Moderna vaccine doses through Covax by August- sources

India expects to receive 3 million to 4 million doses of the Pfizer and Moderna Covid-19 shots through the Covax facility by August, two sources said, as it tries to expand inoculations to prevent..
IndiaTimes - Published

Indemnity issue holds up J&J, Pfizer and Moderna jabs

IndiaTimes - Published

DCGI gives emergency use nod to Moderna’s vaccine

Indian pharma major Cipla will “facilitate” the import of Covid vaccines donated by US biotech major Moderna, possibly in the near future, under licence for restricted use by India’s drug..
IndiaTimes - Published

Covid-19: Govt's five-fold strategy of management; Moderna gets nod as 4th vaccine in India, and more

IndiaTimes - Published

India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon

India on Tuesday cleared the decks for the import of Moderna's Covid vaccine, adding another option to its list of anti-Covid shots. Moderna's vaccine, developed in the United States, will be the..
IndiaTimes - Published

Moderna seeks regulatory approval for its Covid-19 vaccine in India

IndiaTimes - Published

Good news! Pfizer gears up to supply 1 billion vaccine doses to India in 2021, approval in "final stages"

The Indian government may be set to grant indemnity from liability to Pfizer and Moderna in a bid to fast-track their vaccine's approval.
DNA - Published

Moderna offers to sell booster shots from January; indemnity-waiver talks on

US vaccine maker Moderna has offered to sell booster doses of its Covid vaccine to India, from January 2022 even as the government continues to hold negotiations with Moderna and J&J on the indemnity..
IndiaTimes - Published

India in talks with Pfizer, J&J, Moderna for local manufacturing of COVID vaccines: Harsh Vardhan Shringla

Last month saw India getting the first batches of Suptink V vaccines, which will be also produced by Indian companies.
DNA - Published

After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources

Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their Covid-19 jabs in India, the Serum Institute of India (SII) has also sought protection..
IndiaTimes - Published

DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step closer

​In a letter, DCGI Chief VG Somani letter said that this will be applicable for vaccines that have already been approved for restricted use by the US FDA, EMA, UK MHRA, PMDA Japan or listed for..
IndiaTimes - Published

COVID-19: Big relief for foreign vaccine makers as DCGI exempts post-approval bridging trials

Cipla, which has been looking to commit USD 1 billion into bringing Moderna's single-dose mRNA booster vaccine to India, also requested an exemption.
DNA - Published

Government in talks to boost vaccine arsenal

The government is in talks with global vaccine giants Moderna and Pfizer to source Covid-19 shots on an immediate basis, to increase supply in the next two-three months itself. While the Centre expects..
IndiaTimes - Published

Moderna's single-dose Covid-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021

Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in..
IndiaTimes - Published

Moderna refuses to send vaccine doses directly to Punjab government, here's why

Divulging further, the State Nodal Officer said that reply was received from Moderna only in which the company refused to deal with State Government.
DNA - Published Also reported by •IndiaTimes

Will deal only with Centre: Pfizer, Moderna

Massachusetts-based biotechnology company Moderna, which has developed a messenger RNA (mRNA) vaccine to tackle Covid-19, has declined the Punjab government’s request for direct supply of its vaccine..
IndiaTimes - Published

Covid-19: Private hospital chains in talks to offer imported vaccines

Private hospital chains across the country, including the Chennai-based Apollo group and Delhi-based Fortis Healthcare, and Mumbai-based Hinduja Hospital, are discussing modalities to offer..
IndiaTimes - Published

India paves way for foreign Covid-19 vaccines: Side effects, risks of Pfizer, Moderna, Sputnik, J&J

IndiaTimes - Published

Covid-19 vaccine: Pfizer, J&J entry could still be months away

US pharma biggies Pfizer, Johnson & Johnson and Moderna could be amongst the potential gainers of the government’s decision to fast-track approvals for foreign-produced Covid-19 vaccines. While..
IndiaTimes - Published

India ​seeks imports of Covid vaccines as cases soar

India is to fast-track emergency approvals for Covid-19 vaccines that have been authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson, and Moderna..
IndiaTimes - Published

Mix and match vaccine study extended to include Moderna and Novavax jabs

mix and match vaccine study extended to include moderna and novavax jabs
A study assessing the benefits of mixing and matching coronavirus vaccines has been extended to include the Moderna and Novavax jabs.
Sky News - Published

'More than enough' doses of Pfizer and Moderna for under-30s, says Hancock

The UK has "more than enough" doses of Pfizer and Moderna jabs for under-30s, Health Secretary Matt Hancock has told Sky News.
Sky News - Published

Everything you need to know about the Moderna vaccine

everything you need to know about the moderna vaccine
The Moderna coronavirus vaccine is the third jab to be rolled out in the UK, alongside the Pfizer/BioNTech and Oxford University-AstraZeneca jabs.
Sky News - Published

Dolly Parton Gets First Dose of Moderna COVID Vaccine, Busts out New Song

Dolly Parton's employing her enormous talent and wealth to encourage folks to follow in her awesome footsteps, and get the COVID-19 vaccine. The beloved "9 to 5" singer got her first dose of the.. - Published